CAM
RMD icon

Claret Asset Management’s ResMed RMD Stock Holding History

Claret Asset Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$264K Buy
+1,357
New +$281K 0.03% 161

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Claret Asset Management's RMD Position: Q2 2026 in Review

Claret Asset Management opened a new position in ResMed (RMD) in Q2 2026: 1,357 shares worth $264K. The stake represents 0.03% of the portfolio and ranks #161 among its holdings.

882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Claret Asset Management held 1,357 shares of ResMed worth $264K as of Q2 2026.
  • ResMed was a new Claret Asset Management position in Q2 2026.
  • ResMed made up 0.03% of Claret Asset Management's portfolio in Q2 2026, its #161 holding.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.